PureTech Health PLC | Ownership

Companies that own PureTech Health PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Asset Management Ltd.
75,964,145
26.89%
167,148
0.19%
03/01/2017
Lansdowne Partners (UK) LLP
21,364,916
7.56%
9,495,518
0.28%
03/01/2017
Jupiter Asset Management Ltd.
11,985,304
4.24%
0
0.08%
12/01/2017
Baillie Gifford & Co.
11,869,398
4.2%
-660,439
0.02%
03/01/2017
Ruffer LLP
7,589,000
2.69%
254,000
0.16%
08/01/2018
Northern Trust Global Investments Ltd. (Securities Lending)
5,079,000
1.8%
290,000
0.23%
08/01/2018
Hargreave Hale Ltd.
4,400,000
1.56%
150,000
0.1%
08/01/2018
Majedie Asset Management Ltd.
3,971,130
1.41%
-551,786
0.05%
07/31/2018
Legal & General Investment Management Ltd.
2,377,000
0.84%
12,000
0%
08/01/2018
Lombard Odier Asset Management (Europe) Ltd.
2,305,888
0.82%
50,663
0.09%
07/31/2018

About PureTech Health

View Profile
Address
6 Tide Street
Boston Massachusetts 02210
United States
Employees -
Website http://puretechhealth.com/
Updated 07/08/2019
PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Growth Stage Affiliates, Project Phase Programmes, Independent Affiliate Programmes, and Parent Company and Other. The Growth Stage Affiliates segment focuses on the development on products to solve major healthcare problems in varied markets.